Literature DB >> 22178897

PIG3: a novel link between oxidative stress and DNA damage response in cancer.

Athanassios Kotsinas1, Vimla Aggarwal, E-Jean Tan, Brynn Levy, Vassilis G Gorgoulis.   

Abstract

Reactive oxygen species (ROS), the most prominent free radicals produced in cells, can have both beneficial and detrimental effects on them. Many genes are known to be involved in ROS regulation. P53 inducible gene 3 (PIG3 or TP53I3) was identified in an analysis of genes induced by p53 before the onset of apoptosis. It is a widely conserved gene between many species. Until now it has been shown to exert two disparate cellular roles. The first is that of ROS producer linked to p53 induced apoptosis. In this context, it exhibits a NADPH dependent reductase activity with orthoquinones. The second is that of a component of the DNA damage response pathway. While it is considered as a p53 dependent pro-apoptotic gene, it is rarely affected in cancer. This data does not support an anti-tumor activity. In the present review we present and discuss aspects on the regulation and function of this factor and how it is implicated in cancer. We conclude by proposing that PIG3 may possibly have a role in cancer cell survival.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178897     DOI: 10.1016/j.canlet.2011.12.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  Identification of prohibitin and prohibiton as novel factors binding to the p53 induced gene 3 (PIG3) promoter (TGYCC)(15) motif.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Luo Wang; David G Johnson; Qingyi Wei
Journal:  Biochem Biophys Res Commun       Date:  2014-01-03       Impact factor: 3.575

2.  HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia.

Authors:  Wancheng Guo; Daomiao Liang; Peilong Wang; Le Yin; Huifang Zhang; Cheng Xing; Zineng Huang; Yinghua Wu; Heng Li; Zhao Cheng; Xiaojuan Xiao; Jing Liu; Zhihua Wang; Hongling Peng
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-10

3.  Functional repeats (TGYCC)n in the p53-inducible gene 3 (PIG3) promoter and susceptibility to squamous cell carcinoma of the head and neck.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Luo Wang; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2012-12-14       Impact factor: 4.944

4.  Amino-terminal p53 mutations lead to expression of apoptosis proficient p47 and prognosticate better survival, but predispose to tumorigenesis.

Authors:  Beng Hooi Phang; Rashidah Othman; Gaelle Bougeard; Ren Hui Chia; Thierry Frebourg; Choong Leong Tang; Peh Yean Cheah; Kanaga Sabapathy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

Review 5.  Defenses against Pro-oxidant Forces - Maintenance of Cellular and Genomic Integrity and Longevity.

Authors:  David Murray; Razmik Mirzayans; William H McBride
Journal:  Radiat Res       Date:  2018-07-24       Impact factor: 2.841

Review 6.  Oxidative Stress in Cancer Cell Metabolism.

Authors:  Saniya Arfin; Niraj Kumar Jha; Saurabh Kumar Jha; Kavindra Kumar Kesari; Janne Ruokolainen; Shubhadeep Roychoudhury; Brijesh Rathi; Dhruv Kumar
Journal:  Antioxidants (Basel)       Date:  2021-04-22

7.  Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.

Authors:  Susana Graciela Kalko; Sonia Paco; Cristina Jou; Maria Angels Rodríguez; Marija Meznaric; Mihael Rogac; Maja Jekovec-Vrhovsek; Monica Sciacco; Maurizio Moggio; Gigliola Fagiolari; Boel De Paepe; Linda De Meirleir; Isidre Ferrer; Manel Roig-Quilis; Francina Munell; Julio Montoya; Ester López-Gallardo; Eduardo Ruiz-Pesini; Rafael Artuch; Raquel Montero; Ferran Torner; Andres Nascimento; Carlos Ortez; Jaume Colomer; Cecilia Jimenez-Mallebrera
Journal:  BMC Genomics       Date:  2014-02-01       Impact factor: 3.969

8.  Lutein Treatment Effects on the Redox Status and Metalloproteinase-9 (MMP-9) in Oral Cancer Squamous Cells-Are There Therapeutical Hopes?

Authors:  Dan Alexandru Enășescu; Mihaela Georgeta Moisescu; Marina Imre; Maria Greabu; Alexandra Ripszky Totan; Iuliua Stanescu-Spinu; Marian Burcea; Crenguta Albu; Daniela Miricescu
Journal:  Materials (Basel)       Date:  2021-05-31       Impact factor: 3.623

9.  A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer.

Authors:  Shuai Gao; Chen-Lin Hsieh; Meenakshi Bhansali; Archana Kannan; Lirim Shemshedini
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

10.  Oxidants, antioxidants and the current incurability of metastatic cancers.

Authors:  Jim Watson
Journal:  Open Biol       Date:  2013-01-08       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.